missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30131897

Invitrogen™ Nipocalimab Humanized Recombinant Human Monoclonal Antibody

Product Code. 30131897
Change view
Click to view available options
Quantity:
100 μg
Unit Size:
100µg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
30131897 100 μg 100µg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 30131897 Supplier Invitrogen™ Supplier No. MA554947

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Human Recombinant Monoclonal Antibody

Compatible with Direct ELISA.

Nipocalimab works by binding to the neonatal Fc receptor (FcRn), inhibiting its interaction with immunoglobulin G (IgG), thereby reducing the levels of pathogenic IgG antibodies.
TRUSTED_SUSTAINABILITY

Specifications

Antigen Nipocalimab Humanized
Applications ELISA
Classification Recombinant Monoclonal
Concentration 2.53 mg/mL
Conjugate Unconjugated
Formulation PBS with no preservative
Gene Alias JNJ 80202135; M 281
Host Species Human
Immunogen Recombinant Human FCGRT/FCRN.
Purification Method Protein A/G
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Product Type Antibody
Form Liquid
Isotype IgG1 λ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.